Exogenous interleukin-1beta restores impaired Langerhans cell migration in aged skin
2004; Oxford University Press; Volume: 150; Issue: 6 Linguagem: Inglês
10.1111/j.1365-2133.2004.05973.x
ISSN1365-2133
AutoresM. Bhushan, Marie Cumberbatch, Rebecca J. Dearman, Ian Kimber, C.E.M. Griffiths,
Tópico(s)Contact Dermatitis and Allergies
ResumoBritish Journal of DermatologyVolume 150, Issue 6 p. 1217-1218 Exogenous interleukin-1β restores impaired Langerhans cell migration in aged skin M. Bhushan, M. Bhushan Dermatopharmacology Unit, The Dermatology Centre, University of Manchester, Hope Hospital, Manchester M6 8HD, U.K. *Syngenta Central Toxicology Laboratory, Alderley Park, Macclesfield, Cheshire SK10 4TJ, U.K.Search for more papers by this authorM. Cumberbatch, M. Cumberbatch Dermatopharmacology Unit, The Dermatology Centre, University of Manchester, Hope Hospital, Manchester M6 8HD, U.K. *Syngenta Central Toxicology Laboratory, Alderley Park, Macclesfield, Cheshire SK10 4TJ, U.K.Search for more papers by this authorR.J. Dearman, R.J. Dearman Dermatopharmacology Unit, The Dermatology Centre, University of Manchester, Hope Hospital, Manchester M6 8HD, U.K. *Syngenta Central Toxicology Laboratory, Alderley Park, Macclesfield, Cheshire SK10 4TJ, U.K.Search for more papers by this authorI. Kimber, I. Kimber Dermatopharmacology Unit, The Dermatology Centre, University of Manchester, Hope Hospital, Manchester M6 8HD, U.K. *Syngenta Central Toxicology Laboratory, Alderley Park, Macclesfield, Cheshire SK10 4TJ, U.K.Search for more papers by this authorC.E.M. Griffiths, C.E.M. Griffiths Dermatopharmacology Unit, The Dermatology Centre, University of Manchester, Hope Hospital, Manchester M6 8HD, U.K. *Syngenta Central Toxicology Laboratory, Alderley Park, Macclesfield, Cheshire SK10 4TJ, U.K.Search for more papers by this author M. Bhushan, M. Bhushan Dermatopharmacology Unit, The Dermatology Centre, University of Manchester, Hope Hospital, Manchester M6 8HD, U.K. *Syngenta Central Toxicology Laboratory, Alderley Park, Macclesfield, Cheshire SK10 4TJ, U.K.Search for more papers by this authorM. Cumberbatch, M. Cumberbatch Dermatopharmacology Unit, The Dermatology Centre, University of Manchester, Hope Hospital, Manchester M6 8HD, U.K. *Syngenta Central Toxicology Laboratory, Alderley Park, Macclesfield, Cheshire SK10 4TJ, U.K.Search for more papers by this authorR.J. Dearman, R.J. Dearman Dermatopharmacology Unit, The Dermatology Centre, University of Manchester, Hope Hospital, Manchester M6 8HD, U.K. *Syngenta Central Toxicology Laboratory, Alderley Park, Macclesfield, Cheshire SK10 4TJ, U.K.Search for more papers by this authorI. Kimber, I. Kimber Dermatopharmacology Unit, The Dermatology Centre, University of Manchester, Hope Hospital, Manchester M6 8HD, U.K. *Syngenta Central Toxicology Laboratory, Alderley Park, Macclesfield, Cheshire SK10 4TJ, U.K.Search for more papers by this authorC.E.M. Griffiths, C.E.M. Griffiths Dermatopharmacology Unit, The Dermatology Centre, University of Manchester, Hope Hospital, Manchester M6 8HD, U.K. *Syngenta Central Toxicology Laboratory, Alderley Park, Macclesfield, Cheshire SK10 4TJ, U.K.Search for more papers by this author First published: 22 June 2004 https://doi.org/10.1111/j.1365-2133.2004.05973.xCitations: 20 Professor C.E.M.Griffiths. E-mail: christopher.griffiths@man.ac.uk Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat No abstract is available for this article.Citing Literature Volume150, Issue6June 2004Pages 1217-1218 RelatedInformation
Referência(s)